Navigation Links
Radiofrequency Ablation Devices Market is Expected to Reach USD 1.0 Billion Globally in 2018: Transparency Market Research
Date:7/22/2013

Albany, NY (PRWEB) July 22, 2013

According to a new market report published by Transparency Market Research, "Radiofrequency Ablation Devices Market for Pain Management- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the global radiofrequency ablation devices market for pain management was valued at USD 296.6 million in 2011, and is expected to grow at a CAGR of 19.4% from 2012 to 2018, and to reach an estimated value of USD 1,027.6 million in 2018.

Related Report : Biosensors Market
http://www.transparencymarketresearch.com/biosensors-market.html

Radiofrequency ablation is a minimally invasive surgical procedure involving temperature controlled destruction of dysfunctional or cancerous tissues. Use of this technology for pain management refers to heat destruction of nerves conducting pain impulses, to relieve the patient of chronic pain. The market for RF ablation devices for pain management application is expected to record a high growth rate during the forecast period, owing to the rising demand of minimally invasive surgeries, high efficacy and short duration of the procedure.

The disposables segment accounted for the largest share of the market in 2011 and is expected to be the fastest growing segment during the forecast period. This was followed by the capital equipment segment and the reusables segment in 2011. Geographically, North America accounted for the largest share in 2011, while Asia-Pacific is expected to be the fastest growing region from 2012 to 2018 at a CAGR of 20.6%.

Browse the full report with TOC at http://www.transparencymarketresearch.com/radiofrequency-ablation-devices.html

This market is dominated by a few major players, namely, Cosman Medical, Integra-Radionics, Kimberly Clark-Baylis, NeuroTherm and Stryker Corporation. Of these, Kimberly-Clark accounted for the largest market share in 2011, followed by NueroTherm.

Radiofrequency ablation is a medical procedure involving use of high frequency electromagnetic waves to generate heat which is used to treat a medical condition. This technology finds application in various fields of medicine like tumor ablation in oncology, cardiac rhythm management, endometrial ablation in gynecology, renal denervation for hypertension, cosmetology and pain management. This report focuses on the RF ablation devices market for the pain management application area. The basic principle underlying pain management using RF ablation is heating up the nerves that send pain signals to the affected area so that their impulse transfer activity is hampered.

Browse All Market Research Reports: http://www.transparencymarketresearch.com/

Read the full story at http://www.prweb.com/releases/2013/7/prweb10950371.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. GAP-AF study helps to define optimal approach to ablation
2. New ablation technique holds promise for liver cancer patients
3. INTIO Introduces Intra-Procedural SyncVIEW™ for Real-time Confirmation of the Ablation Zone
4. Gold standards of success defined for AF ablation
5. Fine tuning cardiac ablation could lead to quicker results for patients with arrhythmias
6. Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent)
7. Endoscopy Devices Market Worth $9.7 Billion by 2016 - New Report by MarketsandMarkets
8. Mesh Lawsuits Involving C.R. Bard, Ethicon Transvaginal Mesh Devices Continue to Mount in New Jersey State Litigation, Bernstein Liebhard LLP Reports
9. Manufacturers Failed to Warn About Defective Transvaginal Mesh Devices, Parker Waichman LLP Alleges in Lawsuit
10. Spinal Surgery and Implants Devices Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research
11. Rijuven Debuts CardioSleeve, an FDA Cleared Stethoscope Attachment with 3-Lead ECG and Digital Auscultation that Wirelessly Connects to Mobile Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... ... with HIV because it is not known to have significant interactions with antiretroviral ... to both lower cholesterol levels and dampen inflammation in the bloodstream. , While ...
(Date:4/24/2017)... ... 24, 2017 , ... Labs often perform the same operations ... operators and management to assess these processes with a critical eye—particularly in the ... , Created with the help of both internal and external process experts, ...
(Date:4/24/2017)... , ... April 24, 2017 , ... “Reflections of God’s ... God. “Reflections of God’s Work” is the creation of published author, Jerri Broglin, a ... comfort. , “I believe this a great eye-opener for those searching for answers, ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue ... Oral Reconstruction Foundation will present its annual Global Symposium at the Fontainebleau Hotel ...
(Date:4/24/2017)... Spain (PRWEB) , ... April 24, 2017 , ... ... on the development of next generation neuro-thrombectomy systems for the treatment of Acute ... and manufacture its ANCD BRAIN device as the product advances towards regulatory and ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Zimmer Biomet Holdings, Inc. (NYSE and ... announced that it will be participating in the Deutsche ... InterContinental Hotel in Boston, Massachusetts ... at 11:20 a.m. Eastern Time. A live ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .  The ...
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... , April 20, 2017 ... platform, the first non-viral gene expression technology that enables ... the eye to address a wide range of ophthalmic ... Medicines and Healthcare products Regulatory Agency (MHRA) to advance ... ...
Breaking Medicine Technology: